Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03898167 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Self-Testing to Increase Screening
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2,474
- Enrollment target
NCT03898167: Completed NA study, sponsored by Baylor College of Medicine.
NCT03898167 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 2,474 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03898167, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,474 participants
- Enrollment target
Study Summary
Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved minority women in a safety-net health system.
Primary Outcome
cervical cancer screening participation within 6 months, defined as return of a mailed HPV self-collection kit or attendance for clinic-based screening.
Interventions
- BEHAVIORAL Patient Navigation
- BEHAVIORAL Telephone Recall
- BEHAVIORAL Mailed HPV Self-Sampling Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,474 participants |
| Start Date | 2020-02-13 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT03898167 record still lists
NCT03898167 is an interventional study that assigns participants to a tested intervention. Its 2,474 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% higher).
The record links to 0 conditions, and to 3 interventions - of which Patient Navigation is the first listed.
NCT03898167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03898167 about?
NCT03898167 is a clinical study titled "Prospective Evaluation of Self-Testing to Increase Screening". Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved...
What is the current status of trial NCT03898167?
This trial is currently completed. It is a NA study. The enrollment target is 2,474 participants. The study started on 2020-02-13. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT03898167?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), Telephone Recall (BEHAVIORAL), Mailed HPV Self-Sampling Kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT03898167?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03898167's enrollment target sits among peer trials
2,474 45th of 2000 higher than 1,956 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI